Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Small Cell Lung Carcinoma 1Lymphoma 1Leukemia, Myeloid, Acute 1Hodgkin Disease 1Congenital Abnormalities 1Blast Crisis 1Anemia, Refractory, with Excess of Blasts 1

Interventions

fludarabine phosphate 9Cyclophosphamide 9Whole-Body Irradiation 8Mycophenolic Acid 8Cyclosporine 8Cord Blood Stem Cell Transplantation 7fludarabine 5Peripheral Blood Stem Cell Transplantation 4Busulfan 4Arsenic Trioxide 4Antilymphocyte Serum 4Transplantation 3Thiotepa 3Tacrolimus 3Radiotherapy 3Etoposide 3Cytarabine 3Methylprednisolone 2Methotrexate 2Melphalan 2Carmustine 2Azacitidine 2thymoglobulin 1lonafarnib 1lintuzumab 1itacitinib 1Vorinostat 1Tretinoin 1Tetradecanoylphorbol Acetate 1Teriparatide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Anemia, Refractory, with Excess of Blasts × Podophyllotoxin × Clear all
NCT00540995 2023-11-30

Busulfan, Etoposide, and Intensity-Modulated Radiation Therapy Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Myeloid Cancer

City of Hope Medical Center

Phase 1/2 Terminated
25 enrolled 9 charts
Classical hematologyOther hematologic neoplasm

Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡